Malignancy in Systemic Lupus Erythematosus (SLE) Patients

BACKGROUND: Malignancies are among the leading causes of death in Systemic Lupus Erythematosus (SLE) patients with studies reporting a higher prevalence of malignancy in SLE patients compared to the general population. We wanted to determine the frequency of cancer in a cohort of SLE patients and id...

Descripción completa

Detalles Bibliográficos
Autores principales: Cader, Rizna Abdul, Yee, Amy Khoo Mei, Yassin, Azrul, Ahmad, Ismail, Haron, Siti Nurfatin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428534/
https://www.ncbi.nlm.nih.gov/pubmed/30583682
http://dx.doi.org/10.31557/APJCP.2018.19.12.3551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428534/
https://www.ncbi.nlm.nih.gov/pubmed/30583682
http://dx.doi.org/10.31557/APJCP.2018.19.12.3551

Ejemplares similares